• Investment World
• eWorld
• Brand Line
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest
• The New Manager

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources
• In Focus
• In Depth

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

Our Bureau

Bangalore, July 3

Bal Pharma Ltd has posted sales turnover of Rs 76.47 crore for the year ended March 31, 2006, or 27 per cent growth over the previous year's figure of Rs 60.03 crore. Profit before tax was Rs 3.98 crore, up 62 per cent over the previous year. PAT also went up by 113 per cent at Rs 3.33 crore. The board cleared 7.5 per cent dividend on the expanded capital of Rs 10.44 crore. The company's performance was affected by the introduction of the MRP-based excise regime and downward revision of incentives retrospectively. Bal Pharma plans Rs 32-crore capacity expansion. The Rs 18-crore formulations plant at Uttaranchal, meant for exports to the regulated markets is under way.

More Stories on : Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Aditya Birla Nuvo's net profit up

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line